IRIS - Res&Arch Institutional Research Information System - Research & Archive

PARNETTI, Lucilla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.996
AS - Asia 10.482
EU - Europa 9.731
SA - Sud America 2.009
AF - Africa 279
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 14
Totale 36.540
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.678
SG - Singapore 4.943
IE - Irlanda 1.747
BR - Brasile 1.576
UA - Ucraina 1.434
RU - Federazione Russa 1.407
CN - Cina 1.393
IT - Italia 1.360
HK - Hong Kong 1.341
VN - Vietnam 1.131
DE - Germania 770
SE - Svezia 753
FR - Francia 652
FI - Finlandia 529
KR - Corea 363
GB - Regno Unito 330
IN - India 232
TR - Turchia 163
CA - Canada 156
BD - Bangladesh 153
AR - Argentina 152
IQ - Iraq 126
AT - Austria 103
PL - Polonia 103
NL - Olanda 100
MX - Messico 91
JP - Giappone 89
RO - Romania 85
ZA - Sudafrica 73
UZ - Uzbekistan 72
PK - Pakistan 68
ID - Indonesia 66
CH - Svizzera 65
CO - Colombia 60
VE - Venezuela 59
SA - Arabia Saudita 55
EC - Ecuador 52
ES - Italia 52
BE - Belgio 48
CZ - Repubblica Ceca 48
CL - Cile 36
MA - Marocco 31
EG - Egitto 29
PH - Filippine 28
JO - Giordania 27
PY - Paraguay 26
GR - Grecia 25
DZ - Algeria 24
KE - Kenya 24
TN - Tunisia 24
AE - Emirati Arabi Uniti 23
LB - Libano 23
LT - Lituania 23
MY - Malesia 20
NP - Nepal 18
PE - Perù 18
AZ - Azerbaigian 15
ET - Etiopia 14
KZ - Kazakistan 14
AL - Albania 13
AU - Australia 13
BO - Bolivia 13
DK - Danimarca 13
IL - Israele 13
UY - Uruguay 13
NZ - Nuova Zelanda 12
OM - Oman 12
CR - Costa Rica 11
EU - Europa 11
JM - Giamaica 11
HR - Croazia 10
IR - Iran 10
AM - Armenia 9
BG - Bulgaria 9
KG - Kirghizistan 9
PA - Panama 8
PT - Portogallo 8
TH - Thailandia 8
AO - Angola 7
PS - Palestinian Territory 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
DO - Repubblica Dominicana 6
MD - Moldavia 6
NI - Nicaragua 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
BY - Bielorussia 5
GE - Georgia 5
RS - Serbia 5
BH - Bahrain 4
CG - Congo 4
CI - Costa d'Avorio 4
GT - Guatemala 4
HN - Honduras 4
LV - Lettonia 4
LY - Libia 4
QA - Qatar 4
TJ - Tagikistan 4
Totale 36.441
Salva come PNG Salva come JPEG
Città #
Singapore 3.539
Chandler 1.968
Dublin 1.745
Hong Kong 1.327
San Jose 1.123
San Mateo 851
Ashburn 845
Jacksonville 747
Boardman 682
Santa Clara 532
Moscow 519
Dong Ket 479
Altamura 474
Medford 408
Princeton 402
Lauterbourg 396
Perugia 360
Wilmington 357
Seoul 356
Lawrence 355
Beijing 322
Ann Arbor 259
Des Moines 253
Los Angeles 251
Munich 228
The Dalles 211
Ho Chi Minh City 209
Andover 184
New York 163
Hanoi 158
Piscataway 142
São Paulo 132
Helsinki 131
Saint Petersburg 121
San Paolo di Civitate 94
Falls Church 93
Turku 93
Frankfurt am Main 89
Orem 84
Tokyo 82
Norwalk 73
Woodbridge 67
Brooklyn 66
Izmir 66
Warsaw 66
Nuremberg 65
Chennai 64
Montreal 64
Denver 63
Baghdad 58
Dallas 54
Redmond 54
Houston 53
Columbus 52
Amsterdam 49
Stockholm 48
Belo Horizonte 46
London 46
Chicago 45
Rome 45
Tashkent 43
Brussels 42
Atlanta 41
Poplar 41
Shanghai 41
Boston 40
Johannesburg 40
Manchester 38
Rio de Janeiro 38
Phoenix 37
Bucharest 36
Timisoara 35
Toronto 34
Council Bluffs 32
Vienna 32
Curitiba 31
Brasília 29
Da Nang 29
Milan 29
Haiphong 27
Redwood City 27
San Francisco 27
Campinas 26
Mexico City 25
Amman 24
Istanbul 24
Caracas 23
Guangzhou 23
Lahore 22
Riyadh 22
Seattle 22
Lappeenranta 21
Charlotte 20
Den Haag 20
Dhaka 20
Hefei 20
Nairobi 20
New Delhi 20
Fortaleza 19
Lausanne 19
Totale 23.067
Salva come PNG Salva come JPEG
Nome #
CSF and blood biomarkers for Parkinson's disease 198
Repeatable Battery for the Assessment of Neuropsychological Status: Italian Normative Data for Older Adults 176
Apopoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer’s disease and vascular dementia patients 166
A new assay for antiphospholipid antibodies in patient with ischemic stroke 165
102.Evolutionary trends in carotid atherosclerotic plaques: results of a two-year follow-up study using an ultrasound imaging system. 153
a-D-Mannosidses in patients with familial Alzheimer's Disease 152
Effect of acetyl-L-carnitine on serum levels of cortisol and adrenocorticotropic hormone and its clinical effect in patients with senile dementia of Alzheimer type 148
Platelet MAO-B activity and vitamin B12 in old age dementias. 147
First-ever stroke and outcome in patients admitted to Perugia Stroke Unit:predictors for death, dependency, and recurrence of stroke within the first three months. 144
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 143
a-D-Mannosidases in patients with Alzheimer's disease 140
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 133
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 133
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease. 132
Hippocampal epileptogenesis in autoimmune encephalitis 131
Brain SPECT in pathological aging brain: Alzheimer's disease, mild cognitive impairment and age-associated cognitive impairment. 130
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 130
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type 128
Blood pressure and functional aspects of the aging brain. 127
[Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride]. 125
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 125
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease 124
A magnetization transfer study of mild and advanced Parkinson's disease. 124
Swalloving dysfunction: neurovascolar- anatomical correlation. 123
1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. 123
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 123
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) 123
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 122
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 122
99mTc-HMPAO-SPECT nell'invecchiamento cerebrale fisiologico, nei deficit di memoria età correlati e nella malattia di Alzheimer: studio longitudinale a un anno. 121
Cerebrospinal fluid biomarkers in Parkinson disease. 121
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids 121
Acetylcholinesterase and butyrylcholinesterase activity in cerebrospinal fluid of Alzheimer patients before and after 6-months treatment with donepezil. XXXI Congresso Società Italiana di Neurologia 120
99mTc-HMPAO cerebral SPECT in cerebrovascular disease with and without dementia. 119
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. 119
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 119
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 119
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study 119
Brain SPECT in pathological aging brain: Alzheimer’s disease, mild cognitive impairment and age-associated cognitive impairment 117
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 117
Neuropsychological results of long-term therapy with oxiracetam in DAT/MID patients in comparison with a control group 116
B-mode imaging and histomorphometric evaluation of carotid atherosclerosis. 116
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 116
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 116
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 115
Early admission to stroke unit influences clinical outcome 115
A combination of CSF Tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy. 115
Stroke related to carotid artery dissection in a young patient with Takayasu arteritis, systemic lupus erythematosus and antiphospholipid antibody syndrome. 113
99mTc-HMPAO-SPECT contribution in the differential diagnosis of cognitive dysfunction. 113
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 113
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 113
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 113
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 112
Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina. 111
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 111
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test 110
Is multi-infarct dementia representative of vascular dementias? A retrospective study 110
Italian frontotemporal dementia network (FTD group-SINDEM): Sharing clinical and diagnostic procedures in Frontotemporal dementia in Italy 110
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction 110
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 109
Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients. 109
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 109
Expression of d-mannosidase in amyotrophic lateral sclerosis and Alzheimer's disease 108
Influence of dementia on antithrombotic therapy prescribed before stroke in patients with atrial fibrillation. 108
[Drinking-water and cardiovascular mortality]. 108
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies 108
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 108
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 107
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 107
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia 107
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 107
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 106
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice 106
Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome 106
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 105
The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderly 105
Differences in Extracellular Matrix Production and Basic Fibroblast Growth Factor Response in Skin Fibroblasts from Sporadic and Familial Alzheimer’s Disease 105
Amyloid-β: a potential link between epilepsy and cognitive decline 105
Variazioni di attività della paraoxonasi serica nella fase acuta dello stroke ischemico. Stroke'99 Meeting on Cerebrovascular Diseases 104
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 104
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. 104
The Italian version of Cognitive Function Instrument (CFI) for tracking changes in healthy elderly: results at 1-year follow-up 104
Risk factors and stroke subtypes: results of five consecutive years of the Perugia Stroke Registry 103
Brain SPECT in the diagnosis of degenerative dementia. 103
[Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases]. 103
Prevalence and risk of progression of preclinical Alzheimer's disease stages: A systematic review and meta-analysis 103
Association between migraine and headache attributed to stroke: a case-control study. 102
CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group. 102
Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study 102
Lysosomal enzyme activities in human brain 101
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 101
Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment 101
Are we ready for detecting α-synuclein prone to aggregation in patients? The case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as diagnostic tools 101
Differential diagnosis between Alzheimer's disease and other dementias: Role of cerebrospinal fluid biomarkers 101
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 101
Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers 101
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type. 101
PEG-J replacement for duodenal levodopa infusion in Parkinson's disease patients: a retrospective study 101
Cerebrospinal fluid biomarkers and white matter lesions: can we know more? 100
Atrial fibrillation and stroke. 100
Totale 11.746
Salva come PNG Salva come JPEG
Categoria #
all - tutte 165.459
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.459
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021901 0 0 0 0 0 0 0 0 0 123 240 538
2021/20223.192 80 580 88 141 96 85 53 944 100 131 372 522
2022/20236.532 437 1.297 81 564 491 799 15 271 2.295 18 197 67
2023/20242.424 184 280 126 59 27 14 463 97 273 99 397 405
2024/20256.102 86 606 234 283 761 351 191 456 1.231 417 995 491
2025/202613.397 1.032 1.005 782 1.935 1.889 1.263 2.360 717 1.440 974 0 0
Totale 37.403